These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 27535406)

  • 1. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).
    Wong ML; McMurry TL; Schumacher JR; Hu CY; Stukenborg GJ; Francescatti AB; Greenberg CC; Chang GJ; McKellar DP; Walter LC; Kozower BD
    J Oncol Pract; 2018 Oct; 14(10):e631-e643. PubMed ID: 30207852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
    Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
    Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
    Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
    Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of administrative claims to identify incident cases of lung cancer: a comparison of 3 health plans.
    Ramsey SD; Scoggins JF; Blough DK; McDermott CL; Reyes CM
    J Manag Care Pharm; 2009 Oct; 15(8):659-68. PubMed ID: 19803555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity and Survival in Lung Cancer Patients.
    Islam KM; Jiang X; Anggondowati T; Lin G; Ganti AK
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1079-85. PubMed ID: 26065838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
    Mettlin CJ; Menck HR; Winchester DP; Murphy GP
    Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients.
    Klabunde CN; Harlan LC; Warren JL
    Med Care; 2006 Oct; 44(10):921-8. PubMed ID: 17001263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of older adults with Alzheimer's and related dementias among patients newly diagnosed with cancer: A comparison of methodological approaches.
    Keeney T; Miller A; Gilissen J; Coombs LA; Ritchie CS; McCarthy EP
    J Geriatr Oncol; 2024 Sep; 15(7):101842. PubMed ID: 39122573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Data Base report on patterns of childhood cancers in the United States.
    Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
    Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
    Eytan DF; Blackford AL; Eisele DW; Fakhry C
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):85-92. PubMed ID: 30252608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
    Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.